Cardlytics, Inc. (CDLX) scores 47 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $1.28, representing a 36% margin of safety. Quantitative score: 65/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.